Speaker illustration

Mr Bart Johan Van Essen

University Medical Centre Groningen, Groningen (Netherlands (The))

Member of:

Heart Failure Association

Serum amyloid a1 reflects activation of interleukin 1b, 6, and 17 and is specifically upregulated in heart failure with a preserved ejection fraction

Event: Heart Failure 2025

Topic: Pathophysiology

Session: Advances in mechanisms of heart failure

Thumbnail

Obesity and inactivity cluster is the strongest predictor of incident heart failure in a population-based study

Event: Heart Failure 2025

Topic: Epidemiology, Prognosis, Outcome

Session: From epidemiology to outcomes

Thumbnail

The sex-specific incidence and contribution of modifiable risk factors on new-onset heart failure with reduced and preserved ejection fraction.

Event: Heart Failure 2024

Topic: Epidemiology, Prognosis, Outcome

Session: Patient phenotypes and heart failure management

Thumbnail

Distinguishing heart failure with reduced ejection fraction from heart failure with preserved ejection fraction: a phenomics approach.

Event: Heart Failure 2024

Topic: Pathophysiology

Session: Chronic heart failure - pathophysiology and mechanisms 5

Thumbnail

Activation of neutrophil extracellular trap formation in patients with heart failure and a preserved ejection fraction

Event: Heart Failure 2023

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Session: Biomarkers definning pathophysiology and prognosis

Thumbnail

Phenotyping heart failure with a supranormal ejection fraction

Event: Heart Failure 2022

Topic: Epidemiology, Prognosis, Outcome

Session: Acute heartfailure from bench to bedside

Thumbnail